267 related articles for article (PubMed ID: 29377268)
1. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
[TBL] [Abstract][Full Text] [Related]
2. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
[TBL] [Abstract][Full Text] [Related]
3. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.
Cantu E; Suzuki Y; Diamond JM; Ellis J; Tiwari J; Beduhn B; Nellen JR; Shah R; Meyer NJ; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Crespo M; Demissie E; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Ware LB; Wang F; Feng R; Christie JD;
Am J Transplant; 2016 Mar; 16(3):833-40. PubMed ID: 26663441
[TBL] [Abstract][Full Text] [Related]
4. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.
Christie JD; Robinson N; Ware LB; Plotnick M; De Andrade J; Lama V; Milstone A; Orens J; Weinacker A; Demissie E; Bellamy S; Kawut SM
Am J Respir Crit Care Med; 2007 Jan; 175(1):69-74. PubMed ID: 17023732
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Glycocalyx Shedding Predicts Donor Organ Acceptability and Is Associated With Primary Graft Dysfunction in Lung Transplant Recipients.
Sladden TM; Yerkovich S; Grant M; Zhang F; Liu X; Trotter M; Hopkins P; Linhardt RJ; Chambers DC
Transplantation; 2019 Jun; 103(6):1277-1285. PubMed ID: 30444804
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
[TBL] [Abstract][Full Text] [Related]
8. Construct validity of the definition of primary graft dysfunction after lung transplantation.
Christie JD; Bellamy S; Ware LB; Lederer D; Hadjiliadis D; Lee J; Robinson N; Localio AR; Wille K; Lama V; Palmer S; Orens J; Weinacker A; Crespo M; Demissie E; Kimmel SE; Kawut SM
J Heart Lung Transplant; 2010 Nov; 29(11):1231-9. PubMed ID: 20655249
[TBL] [Abstract][Full Text] [Related]
9. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
[TBL] [Abstract][Full Text] [Related]
11. Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.
Pottecher J; Roche AC; Dégot T; Helms O; Hentz JG; Schmitt JP; Falcoz PE; Santelmo N; Levy F; Collange O; Uring-Lambert B; Bahram S; Schaeffer M; Meyer N; Geny B; Lassalle P; Diemunsch P; Massard G; Kessler R; Steib A;
Transplantation; 2017 Jan; 101(1):112-121. PubMed ID: 27495752
[TBL] [Abstract][Full Text] [Related]
12. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
[TBL] [Abstract][Full Text] [Related]
13. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
Diamond JM; Kawut SM; Lederer DJ; Ahya VN; Kohl B; Sonett J; Palmer SM; Crespo M; Wille K; Lama VN; Shah PD; Orens J; Bhorade S; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
Am J Transplant; 2011 Mar; 11(3):561-7. PubMed ID: 21299834
[TBL] [Abstract][Full Text] [Related]
15. Primary Graft Dysfunction and Mortality Following Lung Transplantation: A Role for Proadrenomedullin Plasma Levels.
Riera J; Senna A; Cubero M; Roman A; Rello J;
Am J Transplant; 2016 Feb; 16(2):634-9. PubMed ID: 26461449
[TBL] [Abstract][Full Text] [Related]
16. Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients.
Bastarache JA; Diamond JM; Kawut SM; Lederer DJ; Ware LB; Christie JD
Gend Med; 2012 Jun; 9(3):154-65. PubMed ID: 22361838
[TBL] [Abstract][Full Text] [Related]
17. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
Shah RJ; Diamond JM; Lederer DJ; Arcasoy SM; Cantu EM; Demissie EJ; Kawut SM; Kohl B; Lee JC; Sonett J; Christie JD; Ware LB
Transl Res; 2012 Dec; 160(6):435-42. PubMed ID: 22989614
[TBL] [Abstract][Full Text] [Related]
18. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
19. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation.
Pelaez A; Force SD; Gal AA; Neujahr DC; Ramirez AM; Naik PM; Quintero DA; Pileggi AV; Easley KA; Echeverry R; Lawrence EC; Guidot DM; Mitchell PO
Am J Transplant; 2010 Apr; 10(4):900-907. PubMed ID: 20121754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
